Boehringer Ingelheim has announced the launch of a solutions-driven programme that seeks to address crucial animal health challenges by creating availability of animal medicine.
The scheme, supported by the Global Alliance for Livestock Veterinary Medicines (GALVmed) and funded by Bill & Melinda Gates Foundation, seeks to bridge current gaps in access, availability, and awareness of animal healthcare solutions for smallholder farmers in Africa.
A German multinational has launched a scheme that will help small-scale farmers in remote regions access animal medical resources to avert animal deaths.
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced the launch of the last-mile initiative, an integrated, solutions-driven programme that seeks to address crucial animal health challenges by creating availability of animal medicine.
The scheme, supported by the Global Alliance for Livestock Veterinary Medicines (GALVmed) and funded by Bill & Melinda Gates Foundation, seeks to bridge current gaps in access, availability, and awareness of animal healthcare solutions for smallholder farmers in Africa.
“The last-mile Initiative will address weak distribution channels and help smallholder farmers in Africa, who currently have low levels of awareness about animal diseases, to increase their knowledge on disease prevention and treatment,” said Enrique Hernandez Pando, Africa Country Head at Boehringer Ingelheim
The initiative, initially launched in Kenya, will expand to other markets in Africa including Benin, Burkina Faso, Cameroon, Chad, Ethiopia, Mali, Nigeria and Tanzania.
The programme seeks to create long-lasting partnerships with the local farming community, in an effort to establish and drive sustainable businesses that are integrated into the wider national economy.
PAYE Tax Calculator
Note: The results are not exact but very close to the actual.
